login
register
Home
Getting Started
ChartMill Overview
Growth Traders
Technical Swing Traders
Long Term Investors
Tools
Stock Screener
Stock Charts
Full Screen Stock Charts
Market Monitor
Sectors
Earnings
Analyzer
Insider Trading
Up- and Downgrades
Stock Market
Top Gainers and Losers
New 52 Week High and Low
Gap Up and Gap Down
Most Active
Premarket Movers
After-Hours Movers
Earnings Calendar
USA Market Overview
Canada Market Overview
Europe Market Overview
Trading Ideas
News
Blog
Documentation
Documentation Center
Videos
Indicators
Properties
Screener Market data
Popular Articles
Bull Flags
Relative Strength
Pocket Pivots
Support and Resistance
RSI Indicator
MACD Indicator
Piotroski F-score
Squeeze Plays
Weinstein
Technical Breakout Setups
Trading Tips
Premarket Movers
Gap Up Stocks
Best Dividend Stocks
Bullish Engulfing Pattern
Ascending Triangle Pattern
Swing Trading
All articles ...
Subscriptions
Swing Trading Course
Account
Disclaimer
Affiliate
Contact
Privacy
PROTHENA CORP PLC (PRTA) Stock News
USA
- NASDAQ:PRTA -
IE00B91XRN20
-
Common Stock
10.3
USD
+0.05 (+0.49%)
Last: 11/18/2025, 1:12:18 PM
Overview
Stock Chart
Technical Analysis
Fundamental Analysis
Analyst Ratings
Earnings Estimates
Financials
Ownership
News
PRTA Latest News, Press Relases and Analysis
All
Press Releases
12 days ago - By: Chartmill
Prothena Corp PLC (NASDAQ:PRTA) Reports Q3 2025 Earnings and Key Pipeline Milestones
6 days ago - By: Benzinga
- Mentions:
ALNY
NVO
PFE
Novo Nordisk's $100 Million Coramitug Shows Promise In Reducing Heart Failure Biomarker
7 days ago - By: Prothena Corporation plc
Prothena Highlights Phase 2 Data for Coramitug (Formerly PRX004) Published in Circulation, Official Journal of AHA
11 days ago - By: Zacks Investment Research
- Mentions:
BMY
NVO
Prothena Q3 Earnings Miss Estimates, Pipeline Progress in Focus
12 days ago - By: Zacks Investment Research
- Mentions:
FBIO
Prothena (PRTA) Reports Q3 Loss, Lags Revenue Estimates
12 days ago - By: Prothena Corporation plc
Prothena Reports Third Quarter 2025 Financial Results and Business Highlights
12 days ago - By: Benzinga
- Mentions:
STVN
PODD
AMRK
SOLV
...
Earnings Scheduled For November 6, 2025
19 days ago - By: Prothena Corporation plc
Prothena to Report Third Quarter 2025 Financial Results on November 6
2 months ago - By: Prothena Corporation plc
Prothena’s Partner Bristol Myers Squibb Obtains Fast Track Designation from the U.S. FDA for BMS-986446 (PRX005), an Anti-MTBR-Tau-Targeting Antibody, for the Treatment of Alzheimer’s Disease
3 months ago - By: Zacks Investment Research
- Mentions:
AMRN
Prothena (PRTA) Up 17.6% Since Last Earnings Report: Can It Continue?
3 months ago - By: Prothena Corporation plc
Prothena to Participate in the Cantor Fitzgerald Global Healthcare Conference
3 months ago - By: Prothena Corporation plc
Prothena Provides Update on PRX012 and Announces Results from the Phase 1 ASCENT Clinical Program
3 months ago - By: Stocktwits
- Mentions:
NVO
NVS
Novo Nordisk Commits To Advancing Prothena Corp-Developed Drug Into Late Stage Trial: Retail Turns Hopeful
3 months ago - By: Prothena Corporation plc
Prothena Announces that Novo Nordisk Will Advance Coramitug (Formerly PRX004) into Phase 3 Development for ATTR Amyloidosis with Cardiomyopathy
4 months ago - By: The Motley Fool
Prothena Q2 Revenue Drops 97%
4 months ago - By: Zacks Investment Research
- Mentions:
GYRE
Prothena (PRTA) Reports Q2 Loss, Lags Revenue Estimates
4 months ago - By: Prothena Corporation plc
Prothena Reports Second Quarter 2025 Financial Results and Business Highlights
4 months ago - By: Zacks Investment Research
- Mentions:
RYTM
Earnings Preview: Rhythm Pharmaceuticals, Inc. (RYTM) Q2 Earnings Expected to Decline
4 months ago - By: Prothena Corporation plc
Prothena to Report Second Quarter 2025 Financial Results on August 4
5 months ago - By: Zacks Investment Research
- Mentions:
BMY
NVO
PRTA Dives 53.5% YTD: Will the Restructuring Effort Boost Prospects?
5 months ago - By: Stocktwits
Prothena Shares Get A Boost After Company Slashes Workforce, Lowers 2025 Cash Burn Forecast
5 months ago - By: Prothena Corporation plc
Prothena Announces Corporate Restructuring
5 months ago - By: Yahoo Finance
- Mentions:
MS
VZ
WDC
Why Western Digital Is a ‘Key Name’ in IT Hardware for Morgan Stanley
5 months ago - By: Yahoo Finance
- Mentions:
VZ
ROG
Roche’s Phase 3 Move Boosts Outlook for Prothena Corporation plc (PRTA)
5 months ago - By: Yahoo Finance
- Mentions:
GOOG
META
NVS
MTZ
...
2 Top Artificial Intelligence Stocks to Buy Right Now
5 months ago - By: Prothena Corporation plc
Prothena’s Partner Roche to Advance Prasinezumab into Phase III Development for Early-Stage Parkinson's Disease
6 months ago - By: Yahoo Finance
- Mentions:
GS
BAH
EXTR
AAP
...
Goldman Sachs Downgrades Booz Allen Hamilton to Sell, Cuts PT
6 months ago - By: Yahoo Finance
- Mentions:
OWL
CRWV
BAH
EXTR
...
Blue Owl Invests Additional $750M in AI Data Center Joint Venture
6 months ago - By: Yahoo Finance
- Mentions:
CHKP
LULU
DHI
CMG
Oppenheimer Downgrades Prothena Corporation (NASDAQ:PRTA) to Perform from Outperform
Please enable JavaScript to continue using this application.